Shire PLC

15 Minute Delayed Share Price Glossary Go to Portfolio
Current Chg % Chg Open High Low Volume
1,159.00
+24.00
2.11% 1,139.00 1,173.00 1,138.32 1.20m

Share Price Chart

label: share priceshare price chart showing price and earning per share against datelabel: earning per share

Broker Recommendation (9 Brokers)

STRONG SELL STRONG BUY
HOLD
Key Figures
Market Cap. £6,502.62m PER (pr) 17.6x EPS Growth (pr) 16.1% ROCE/ROIC 83.12%
Shares in issue 561.05m PEG (pr) 1.09f DY (pr) 0.58% Net Gearing 69.0%
Company Background
Sector Health
Activities Focuses on attention deficit and hyperactivity disorder, human genetic therapies and gastrointestinal diseases
TIDM SHP
Index FTSE 100, FTSE 350, Eurotop 300, S&P Europe 350, FTSE All Share, FTSE Techmark All Share, FTSE techMARK 100
Listed LSE - Full

Outlook

(30/10/2009) 3QT: ceo - "Shire continues to deliver excellent growth"
Latest Results
3rd Quarter 30/9/2008 30/9/2009
Turnover £m 1268.21 1322.16
Pre-tax Profit £m 43.45 241.5
EPS (Norm Dil.) p 8.71 32.63
Dividend p 0 5.47
Notes Figures from 2003 in accordance with IFRS. USD to GBP, 2004: 1.93370, 2005: 1.72030, 2006: 1.96330, 2007: 2.0077, 2008: 1.4582. Information taken from admission document dated 16 April 2008
Investment Ratios
  Co. FTSE Sector Market
PER (pr) x 17.63 10.30 12.72
Dividend Yield (pr) % 0.58 4.85 3.92
PEG (pr) f 1.09 0.93 0.23
ROCE % 83.12 52.99 -7.72
Operating Margin % 16.71 16.34 10.26
EPS Growth (pr) % 16.14 3.94 12.50
EV/EBITDA x 12.97 7.41 6.60
Net Gearing % 69.00 94.90 160.37
Net Tangible Asset Value PS p -107.42 -1.06 1.35
Price to Tangible Book Value (PTBV) x -10.79 -8.24 0.69
Price to Cashflow (PCF) x 11.61 8.74 9.33
Price to Sales Ratio (PSR) x 3.03 2.66 2.08
Data provided by Morningstar.
© Copyright 2009 Morningstar. All rights reserved. Please read our Terms of Use and Privacy Policy.